{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T22:31:43Z","timestamp":1759530703056},"reference-count":41,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Janssen Korea, Ltd., Korea"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1016\/j.pnpbp.2012.06.024","type":"journal-article","created":{"date-parts":[[2012,7,11]],"date-time":"2012-07-11T06:46:40Z","timestamp":1341989200000},"page":"295-300","source":"Crossref","is-referenced-by-count":14,"title":["Relationship between inflammation and metabolic syndrome following treatment with paliperidone for schizophrenia"],"prefix":"10.1016","volume":"39","author":[{"given":"Kyoung-Sae","family":"Na","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Won-Hyoung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Han-Yong","family":"Jung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seong Gon","family":"Ryu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyung Joon","family":"Min","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ki-Chang","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong-Sik","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin-Sang","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong Min","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chul-Eung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pnpbp.2012.06.024_bb0005","series-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"APA","year":"1994"},{"key":"10.1016\/j.pnpbp.2012.06.024_bb0010","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1192\/bjp.bp.109.067512","article-title":"Twenty-five year mortality of a community cohort with schizophrenia","volume":"196","author":"Brown","year":"2010","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.pnpbp.2012.06.024_bb0015","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.2337\/diabetes.53.8.2087","article-title":"Intra-abdominal fat is a major determinant of the National Cholesterol Education Program Adult Treatment Panel III criteria for the metabolic syndrome","volume":"53","author":"Carr","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.pnpbp.2012.06.024_bb0020","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1177\/0003319709344575","article-title":"Association of white blood cell count and peripheral arterial disease in patients with and without traditional risk factors","volume":"61","author":"Chen","year":"2010","journal-title":"Angiology"},{"key":"10.1016\/j.pnpbp.2012.06.024_bb0025","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.2165\/11204840-000000000-00000","article-title":"Paliperidone extended release: a review of its use in the management of schizophrenia","volume":"70","author":"Chwieduk","year":"2010","journal-title":"Drugs"},{"key":"10.1016\/j.pnpbp.2012.06.024_bb0030","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.schres.2007.03.003","article-title":"Efficacy, safety and early response of paliperidone extended-release tablets (paliperidone ER): results of a 6-week, randomized, placebo-controlled study","volume":"93","author":"Davidson","year":"2007","journal-title":"Schizophr Res"},{"key":"10.1016\/j.pnpbp.2012.06.024_bb0035","doi-asserted-by":"crossref","first-page":"173","DOI":"10.2337\/diacare.14.3.173","article-title":"Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease","volume":"14","author":"DeFronzo","year":"1991","journal-title":"Diabetes Care"},{"key":"10.1016\/j.pnpbp.2012.06.024_bb0040","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/S0140-6736(05)66378-7","article-title":"The metabolic syndrome","volume":"365","author":"Eckel","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.pnpbp.2012.06.024_bb0045","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/YIC.0b013e328314e1f3","article-title":"Efficacy and safety of oral paliperidone extended-release tablets in the treatment of acute schizophrenia: pooled data from three 52-week open-label studies","volume":"23","author":"Emsley","year":"2008","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.pnpbp.2012.06.024_bb0050","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","article-title":"Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)","volume":"285","author":"Expert Panel on Detection Evaluation and Treatment of High Blood Cholesterol in Adults","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.pnpbp.2012.06.024_bb0055","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.schres.2010.02.1028","article-title":"Higher white blood cell counts are associated with an increased risk for metabolic syndrome and more severe psychopathology in non-diabetic patients with schizophrenia","volume":"118","author":"Fan","year":"2010","journal-title":"Schizophr Res"},{"key":"10.1016\/j.pnpbp.2012.06.024_bb0060","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1097\/JCP.0b013e31820fcea3","article-title":"Metabolic effects of olanzapine in patients with newly diagnosed psychosis","volume":"31","author":"Fernandez-Egea","year":"2011","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.pnpbp.2012.06.024_bb0065","doi-asserted-by":"crossref","DOI":"10.1001\/archgenpsychiatry.2011.2","article-title":"Systematic review of early cardiometabolic outcomes of the first treated episode of psychosis","author":"Foley","year":"2011","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pnpbp.2012.06.024_bb0070","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1001\/jama.287.3.356","article-title":"Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey","volume":"287","author":"Ford","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.pnpbp.2012.06.024_bb0075","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1016\/S0140-6736(05)66375-1","article-title":"Prevalence of the metabolic syndrome and overweight among adults in China","volume":"365","author":"Gu","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.pnpbp.2012.06.024_bb0080","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.atherosclerosis.2005.07.020","article-title":"Modification of the NCEP ATP III definitions of the metabolic syndrome for use in Asians identifies individuals at risk of ischemic heart disease","volume":"186","author":"Heng","year":"2006","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.pnpbp.2012.06.024_bb0085","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nature05485","article-title":"Inflammation and metabolic disorders","volume":"444","author":"Hotamisligil","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.pnpbp.2012.06.024_bb0090","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.schres.2010.12.014","article-title":"Cross-sectional prevalence of metabolic syndrome in Korean patients with schizophrenia","volume":"128","author":"Kang","year":"2011","journal-title":"Schizophr Res"},{"key":"10.1016\/j.pnpbp.2012.06.024_bb0095","first-page":"179","article-title":"The foetal origins of the metabolic syndrome\u2014a South African perspective","volume":"13","author":"Levitt","year":"2002","journal-title":"Cardiovasc J S Afr"},{"key":"10.1016\/j.pnpbp.2012.06.024_bb0100","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.amjhyper.2005.10.008","article-title":"Prevalence of metabolic syndrome and its relationship to white blood cell count in a population of Thai men and women receiving routine health examinations","volume":"19","author":"Lohsoonthorn","year":"2006","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.pnpbp.2012.06.024_bb0105","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/j.biopsych.2007.01.017","article-title":"Efficacy and safety of paliperidone extended-release tablets: results of a 6-week, randomized, placebo-controlled study","volume":"62","author":"Marder","year":"2007","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2012.06.024_bb0110","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.schres.2005.07.014","article-title":"Prevalence of the metabolic syndrome in patients with schizophrenia: baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III","volume":"80","author":"McEvoy","year":"2005","journal-title":"Schizophr Res"},{"key":"10.1016\/j.pnpbp.2012.06.024_bb0115","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.biopsych.2009.06.005","article-title":"Inflammatory markers in schizophrenia: comparing antipsychotic effects in phase 1 of the clinical antipsychotic trials of intervention effectiveness study","volume":"66","author":"Meyer","year":"2009","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2012.06.024_bb0120","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1161\/circ.106.25.3143","article-title":"Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report","volume":"106","author":"NCEP Expert Panel","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.pnpbp.2012.06.024_bb0125","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.2169\/internalmedicine.48.2138","article-title":"The prevalence of metabolic syndrome and diabetes increases through the quartiles of white blood cell count in Japanese men and women","volume":"48","author":"Oda","year":"2009","journal-title":"Intern Med"},{"key":"10.1016\/j.pnpbp.2012.06.024_bb0130","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.schres.2010.05.010","article-title":"Low prevalence of obesity and metabolic syndrome in never-treated chronic schizophrenia","volume":"121","author":"Padmavati","year":"2010","journal-title":"Schizophr Res"},{"key":"10.1016\/j.pnpbp.2012.06.024_bb0135","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1161\/01.CIR.0000052939.59093.45","article-title":"Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association","volume":"107","author":"Pearson","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.pnpbp.2012.06.024_bb0140","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1002\/dmr.5610040703","article-title":"Role of insulin in regulation of lipoprotein metabolism in diabetes","volume":"4","author":"Reaven","year":"1988","journal-title":"Diabetes Metab Rev"},{"key":"10.1016\/j.pnpbp.2012.06.024_bb0145","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1161\/01.CIR.0000088846.10655.E0","article-title":"The metabolic syndrome: more than the sum of its parts?","volume":"108","author":"Reilly","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.pnpbp.2012.06.024_bb0150","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0024-3205(02)01646-6","article-title":"Physical consequences of schizophrenia and its treatment: the metabolic syndrome","volume":"71","author":"Ryan","year":"2002","journal-title":"Life Sci"},{"key":"10.1016\/j.pnpbp.2012.06.024_bb0155","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.schres.2008.01.004","article-title":"Metabolic syndrome in first episode schizophrenia\u2014a randomized double-blind controlled, short-term prospective study","volume":"101","author":"Saddichha","year":"2008","journal-title":"Schizophr Res"},{"key":"10.1016\/j.pnpbp.2012.06.024_bb0160","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1001\/archpsyc.64.10.1123","article-title":"A systematic review of mortality in schizophrenia: is the differential mortality gap worsening over time?","volume":"64","author":"Saha","year":"2007","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pnpbp.2012.06.024_bb0165","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.schres.2008.02.013","article-title":"Are metabolic indices different between drug-naive first-episode psychosis patients and healthy controls?","volume":"102","author":"Sengupta","year":"2008","journal-title":"Schizophr Res"},{"key":"10.1016\/j.pnpbp.2012.06.024_bb0170","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.atherosclerosis.2006.04.029","article-title":"The association between circulating white blood cell count, triglyceride level and cardiovascular and all-cause mortality: population-based cohort study","volume":"192","author":"Shankar","year":"2007","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.pnpbp.2012.06.024_bb0175","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1038\/sj.ijo.0801968","article-title":"The prediction of visceral fat by dual-energy X-ray absorptiometry in the elderly: a comparison with computed tomography and anthropometry","volume":"26","author":"Snijder","year":"2002","journal-title":"Int J Obes Relat Metab Disord"},{"key":"10.1016\/j.pnpbp.2012.06.024_bb0180","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.schres.2010.08.030","article-title":"Prevalence of metabolic syndrome among patients with schizophrenia in Japan","volume":"123","author":"Sugawara","year":"2010","journal-title":"Schizophr Res"},{"key":"10.1016\/j.pnpbp.2012.06.024_bb0185","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.brainres.2010.05.060","article-title":"Olanzapine-induced accumulation of adipose tissue is associated with an inflammatory state","volume":"1350","author":"Victoriano","year":"2010","journal-title":"Brain Res"},{"issue":"Suppl. 4","key":"10.1016\/j.pnpbp.2012.06.024_bb0190","first-page":"34","article-title":"Switching antipsychotics as a treatment strategy for antipsychotic-induced weight gain and dyslipidemia","volume":"68","author":"Weiden","year":"2007","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pnpbp.2012.06.024_bb0195","series-title":"The Asia-Pacific perspective. Redefining obesity and its treatment","author":"WHO Western Pacific Region","year":"2000"},{"key":"10.1016\/j.pnpbp.2012.06.024_bb0200","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1001\/jama.292.18.2237","article-title":"The metabolic syndrome, inflammation, and risk of cognitive decline","volume":"292","author":"Yaffe","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.pnpbp.2012.06.024_bb0205","doi-asserted-by":"crossref","first-page":"417","DOI":"10.2165\/00023210-200721050-00005","article-title":"Paliperidone extended release","volume":"21","author":"Yang","year":"2007","journal-title":"CNS Drugs"}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584612001595?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584612001595?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,30]],"date-time":"2019-06-30T16:32:31Z","timestamp":1561912351000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584612001595"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["S0278584612001595"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2012.06.024","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2012,12]]}}}